Gene DX INC:1108521 [17-024640]
Ended Awarded Last action
- Contract number
- HHSN26100001
- Awardee
-
Genedx, LLC UEI H3J4SCC8F671 Part of Opko Health, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,850
Award facts
- Contract value 100% obligated
- $7,850.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$6,463 | |
| Original award | $14,313 |
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Genedx, LLC by National Cancer Institute (National Institutes of Health) on March 29, 2017.
How much is contract HHSN26100001 worth?
The government has obligated $7,850 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a BPA call under HHSN261201600003B, a blanket purchase agreement.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award